PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Michigan Drug Discovery, University of Michigan, Life Science Institute, 210 Washtenaw Avenue, Ann Arbor, MI, 48109, United States; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, North University Building, 428 Church Street, Ann Arbor, MI, 48109, United States. Electronic address: toogood@umich.edu.\', \'Departments of Anesthesiology, Internal Medicine (Rheumatology) and Psychiatry, University of Michigan/Michigan Medicine, Chronic Pain and Fatigue Center, 24 Frank Lloyd Wright Drive, P.O. Box 3885, Ann Arbor, MI, 48109, United States.\', \'Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, North University Building, 428 Church Street, Ann Arbor, MI, 48109, United States.\', \'Cayman Chemical Company, 1180 E. Ellsworth Road, Ann Arbor, MI, 48108, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1043-6618(21)00048-710.1016/j.phrs.2021.105465
?:doi
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 33529750
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all